IART
ANALYST COVERAGE26 analysts
HOLD
-14.9%downside to target
Buy
1142%
Hold
1038%
Sell
519%
11 Buy (42%)10 Hold (38%)5 Sell (20%)
Full report →
PRICE
Prev Close
14.50
Open
14.34
Day Range13.98 – 14.36
13.98
14.36
52W Range8.70 – 16.49
8.70
16.49
69% of range
VOLUME & SIZE
Avg Volume
956.8K
FUNDAMENTALS
P/E Ratio
-2.2x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
0.82
Market-like
TECHNICAL
RSI (14)
66
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 114 days
Sep 9
Key MetricsTTM
Market Cap$1.10B
Revenue TTM$1.64B
Net Income TTM-$495.80M
Free Cash Flow-$10.12M
Gross Margin53.2%
Operating Margin7.5%
Net Margin-30.1%
Return on Equity-47.6%
Return on Assets-13.9%
Debt / Equity1.96
Current Ratio3.38
EPS TTM$-6.44

IART News

About

integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li

Industry
Surgical and Medical Instrument Manufacturing
CEO
Peter Arduini
Stuart EssigCEO, President & Chairman
Christopher WardSenior Director of Investor Relations
Michael D. HutchinsonExecutive Vice President, Chief Legal Officer & Secretary
Robert T. Davis Jr.Executive Vice President & President of Tissue Technologies
Teshtar ElaviaCorporate VP & Chief Technology Officer
Chantal Veillon-BertelootExecutive Vice President & Chief Human Resources Officer
Jessica SmithCorporate VP & Global Quality and Chief Regulatory Officer
Lea Daniels KnightExecutive Vice President & Chief Financial Officer
Laurene IsipVice President of Global Corporate Communications & Public Relations
Harvinder SinghExecutive Vice President & President of International Business
Jeffrey MosebrookSenior Vice President of Finance & Principal Accounting Officer
Michael J. McBreenChief Commercial Officer
Mojdeh PoulPresident, Chief Executive Officer & Director